{"database": "lobbying", "table": "lobbying_activities", "rows": [[2512524, "20267e43-b643-40c9-a768-7020ddb36a57", "Q3", "KEEFE STRATEGIES LLC (FKA KEEFE SINGISER PARTNERS)", 401105192, "CVS HEALTH", 2020, "third_quarter", "PHA", "Issues encompassing general education regarding the pharmacy benefit manager/pharmacy industry. Issues related to access and affordability of health care, prescription drugs and generic drugs. Issues related to continuation of prescription drug access and testing during COVID crisis. Issues related to Medicare Part D rebates.", "HOUSE OF REPRESENTATIVES,SENATE", 55000, null, 0, 0, "2020-10-17T08:32:04.173000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2512524"], "units": {}, "query_ms": 0.34586014226078987, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}